Literature DB >> 22313018

Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes.

Alexia S Peña1, Jennifer J Couper, Jennifer Harrington, Roger Gent, Jan Fairchild, Elaine Tham, Peter Baghurst.   

Abstract

BACKGROUND: Chronic sustained hyperglycemia unequivocally predicts vascular disease in diabetes. However, the vascular risk of glucose variability, including hypoglycemia, is uncertain. Vascular dysfunction is present in children with type 1 diabetes and is a critical precursor of atherosclerosis. We aimed to evaluate the relationship between glucose variability and vascular function in children with type 1 diabetes. SUBJECTS AND METHODS: Fifty-two type 1 diabetes subjects (14 [SD 2.7] years old, 25 males) had continuous glucose monitoring that included 48 h of data used to evaluate glucose variability (mean amplitude of glycemic excursions [MAGE] and other measurements) and hypoglycemia indices (glycemic risk assessment diabetes equation [GRADE] hypoglycemia, Low Blood Glucose Index [LBGI], and observed duration of hypoglycemia). Children with type 1 diabetes and 50 age- and gender-matched controls had assessments of vascular function (flow-mediated dilatation [FMD] and glyceryl trinitrate-mediated dilatation [GTN]).
RESULTS: Children with type 1 diabetes had lower FMD and GTN than controls (P=0.02 and P<0.001, respectively). GRADE hypoglycemia and LBGI were inversely related to FMD (r=-0.36, P=0.009 and r=-0.302, P=0.03, respectively) but did not relate to GTN. GRADE hypoglycemia was independently related to FMD (regression coefficient=-0.25±0.09, P=0.006). MAGE and other measurements of glucose variability measurements did not relate to FMD or GTN.
CONCLUSIONS: Hypoglycemia, but not glucose variability, during continuous glucose monitoring relates to impaired vascular endothelial function in children with type 1 diabetes. Hypoglycemia may be an additional risk factor for early cardiovascular disease, but the effect of glucose variability, independent of glycosylated hemoglobin, on vascular function remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313018      PMCID: PMC3359626          DOI: 10.1089/dia.2011.0229

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  26 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

3.  "J"-index. A new proposition of the assessment of current glucose control in diabetic patients.

Authors:  J M Wójcicki
Journal:  Horm Metab Res       Date:  1995-01       Impact factor: 2.936

4.  Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Roberto Da Ros; Amabile Maier; Gianni Zuodar; Antonio Ceriello
Journal:  Atherosclerosis       Date:  2005-12       Impact factor: 5.162

5.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Authors:  Louis Monnier; Emilie Mas; Christine Ginet; Françoise Michel; Laetitia Villon; Jean-Paul Cristol; Claude Colette
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

6.  Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.

Authors:  E Boland; T Monsod; M Delucia; C A Brandt; S Fernando; W V Tamborlane
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

7.  A novel approach to continuous glucose analysis utilizing glycemic variation.

Authors:  C M McDonnell; S M Donath; S I Vidmar; G A Werther; F J Cameron
Journal:  Diabetes Technol Ther       Date:  2005-04       Impact factor: 6.118

8.  Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus.

Authors:  Ramin Alemzadeh; Cindy Loppnow; Elaine Parton; Midge Kirby
Journal:  Diabetes Technol Ther       Date:  2003       Impact factor: 6.118

9.  Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes.

Authors:  Esko J Wiltshire; Roger Gent; Craig Hirte; Alexia Pena; David W Thomas; Jennifer J Couper
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes.

Authors:  Marga Giménez; Rosa Gilabert; Joan Monteagudo; Anna Alonso; Roser Casamitjana; Carles Paré; Ignacio Conget
Journal:  Diabetes Care       Date:  2010-10-07       Impact factor: 19.112

View more
  16 in total

Review 1.  Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Authors:  Marcello C Bertoluci; Gislaine V Cé; Antônio Mv da Silva; Marco V Wainstein; Winston Boff; Marcia Puñales
Journal:  World J Diabetes       Date:  2015-06-10

Review 2.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

Review 3.  Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?

Authors:  Petter Bjornstad; Kim C Donaghue; David M Maahs
Journal:  Lancet Diabetes Endocrinol       Date:  2018-02-20       Impact factor: 32.069

4.  Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).

Authors:  Marie-Christine Vantyghem; Violeta Raverdy; Anne-Sophie Balavoine; Frédérique Defrance; Robert Caiazzo; Laurent Arnalsteen; Valéry Gmyr; Marc Hazzan; Christian Noël; Julie Kerr-Conte; Francois Pattou
Journal:  J Clin Endocrinol Metab       Date:  2012-09-20       Impact factor: 5.958

5.  Post-Bariatric Hypoglycemia Is Associated with Endothelial Dysfunction and Increased Oxidative Stress.

Authors:  Roberta Lupoli; Ilenia Calcaterra; Giuseppe Annunziata; Giancarlo Tenore; Carmen Rainone; Luigi Schiavo; Brunella Capaldo; Matteo Nicola Dario Di Minno
Journal:  Biomedicines       Date:  2022-04-16

Review 6.  Mitochondrial regulation of diabetic vascular disease: an emerging opportunity.

Authors:  Michael E Widlansky; R Blake Hill
Journal:  Transl Res       Date:  2018-08-04       Impact factor: 7.012

Review 7.  Glucose variability, HbA1c and microvascular complications.

Authors:  Jan Škrha; Jan Šoupal; Jan Škrha; Martin Prázný
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

8.  Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus.

Authors:  Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Yoshiya Tanaka
Journal:  Cardiovasc Diabetol       Date:  2013-01-02       Impact factor: 9.951

9.  Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology--New Possibility to Decrease Cardiovascular Risk?

Authors:  Milena Jamiołkowska; Izabela Jamiołkowska; Włodzimierz Łuczyński; Joanna Tołwińska; Artur Bossowski; Barbara Głowińska Olszewska
Journal:  J Diabetes Res       Date:  2015-11-16       Impact factor: 4.011

10.  Effects of glucose control and variability on endothelial function and repair in adolescents with type 1 diabetes.

Authors:  Robert P Hoffman; Amanda S Dye; Hong Huang; John A Bauer
Journal:  ISRN Endocrinol       Date:  2013-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.